NASDAQ:FPRX
Delisted
Five Prime Therapeutics Stock News
$38.00
+0 (+0%)
At Close: May 27, 2022
Bio Roundup: Alnylam's Billions, COVID-19 Vaccines, Moma Debuts & More
01:28pm, Friday, 17'th Apr 2020
The public markets are moving erratically, but Alnylam Pharmaceuticals showed this week that selling equity isn't the only way for biotech companies to
Five Prime Therapeutics Taps Foundation Med’s Thomas Civik as New CEO
01:21pm, Wednesday, 15'th Apr 2020
Thomas Civik has been appointed president and CEO of Five Prime Therapeutics (NASDAQ: ]). He comes to the South San Francisco biotech from Foundation
Managed Care Pharmacist Program Sees 9:1 Return on Investment
01:00pm, Wednesday, 15'th Apr 2020
A program by pharmacy benefit manager (PBM) Prime Therapeutics LLC (Prime), in which a managed care pharmacist reviewed members' drug therapies including a number of high-cost specialty medications, s
BRIEF-Five Prime Therapeutics Appoints Tom Civik As Chief Executive Officer
01:23pm, Tuesday, 14'th Apr 2020
Five Prime Therapeutics Inc:
Five Prime Therapeutics Reports William Ringo Will No Longer Be CEO, Will Remain As Chair; Names Tom Civik Replacement As CEO
01:12pm, Tuesday, 14'th Apr 2020Five Prime Therapeutics Appoints Tom Civik as Chief Executive Officer
01:00pm, Tuesday, 14'th Apr 2020
Five Prime Therapeutics Appoints Tom Civik as Chief Executive Officer
Five Prime Therapeutics (NASDAQ:FPRX) Stock Price Up 10.2%
09:42am, Saturday, 11'th Apr 2020
Shares of Five Prime Therapeutics Inc (NASDAQ:FPRX) rose 10.2% during mid-day trading on Thursday . The company traded as high as $2.75 and last traded at $2.70, approximately 368,036 shares traded ha
Here's Why Five Prime Therapeutics (NASDAQ:FPRX) Must Use Its Cash Wisely
11:35am, Thursday, 09'th Apr 2020
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Connor Clark & Lunn Investment Management Ltd. Acquires Shares of 20,540 Five Prime Therapeutics Inc (NASDAQ:FPRX)
08:58am, Thursday, 09'th Apr 2020
Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of Five Prime Therapeutics Inc (NASDAQ:FPRX) in the fourth quarter, according to the company in its most recent filing wi
Five Prime Therapeutics Inc (NASDAQ:FPRX) Shares Sold by Citigroup Inc.
09:06am, Sunday, 05'th Apr 2020
Citigroup Inc. reduced its position in Five Prime Therapeutics Inc (NASDAQ:FPRX) by 80.8% during the 4th quarter, HoldingsChannel.com reports. The firm owned 6,848 shares of the biotechnology company�
Five Prime Therapeutics Inc (NASDAQ:FPRX) Position Boosted by AQR Capital Management LLC
08:22am, Sunday, 05'th Apr 2020
AQR Capital Management LLC grew its holdings in shares of Five Prime Therapeutics Inc (NASDAQ:FPRX) by 226.7% in the 4th quarter, according to the company in its most recent filing with the Securities
Axa Reduces Stake in Five Prime Therapeutics Inc (NASDAQ:FPRX)
08:54am, Friday, 03'rd Apr 2020
Axa decreased its stake in shares of Five Prime Therapeutics Inc (NASDAQ:FPRX) by 54.0% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 14
Five Prime Therapeutics Inc (NASDAQ:FPRX) Expected to Announce Earnings of -$1.00 Per Share
10:18am, Wednesday, 01'st Apr 2020
Wall Street analysts expect Five Prime Therapeutics Inc (NASDAQ:FPRX) to post earnings of ($1.00) per share for the current quarter, according to Zacks Investment Research. Five analysts have made est
$5.90 Million in Sales Expected for Five Prime Therapeutics Inc (NASDAQ:FPRX) This Quarter
06:16am, Tuesday, 31'st Mar 2020
Equities research analysts expect Five Prime Therapeutics Inc (NASDAQ:FPRX) to report sales of $5.90 million for the current fiscal quarter, according to Zacks Investment Research. Five analysts have
Have Insiders Been Selling Five Prime Therapeutics, Inc. (NASDAQ:FPRX) Shares This Year?
03:48pm, Thursday, 26'th Mar 2020
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. The...
